Literature DB >> 29703999

Amphetamine maintenance differentially modulates effects of cocaine, methylenedioxypyrovalerone (MDPV), and methamphetamine on intracranial self-stimulation and nucleus accumbens dopamine in rats.

Amy R Johnson1, Matthew L Banks1, Dana E Selley1, S Stevens Negus2.   

Abstract

Amphetamine maintenance is effective clinically to reduce the consumption of the monoamine uptake inhibitor cocaine but not of the monoamine releaser methamphetamine, and its effectiveness in treating the abuse of other psychostimulants is not known. The mechanisms for differential amphetamine-maintenance effectiveness to treat different types of psychostimulant abuse are also not known. Accordingly, the present study compared the effects of amphetamine maintenance on abuse-related behavioral and neurochemical effects of cocaine, methamphetamine, and the "bath salts" constituent 3,4-methylenedioxypyrovalerone (MDPV) in rats. In behavioral studies, rats were trained to lever press for electrical brain stimulation in an intracranial self-stimulation (ICSS) procedure. In neurochemical studies, nucleus accumbens (NAc) levels of dopamine (DA) and serotonin (5-HT) were monitored by in vivo microdialysis. Cocaine, methamphetamine, and MDPV each produced dose-dependent ICSS facilitation and increases in NAc DA; cocaine and methamphetamine also increased NAc 5-HT. Amphetamine maintenance (0.32 mg/kg/h × 7 days) produced (1) sustained increases in basal ICSS and NAc DA with no change in NAc 5-HT, (2) blockade of cocaine but not methamphetamine effects on ICSS and NAc DA, and (3) no blockade of cocaine- or methamphetamine-induced increases in NAc 5-HT. Amphetamine maintenance blocked the increases in NAc DA produced by the selective DA uptake inhibitor MDPV, but it did not block MDPV-induced ICSS facilitation. These results show different effects of amphetamine maintenance on behavioral and neurochemical effects of different psychostimulants. The selective effectiveness of amphetamine maintenance to treat cocaine abuse may reflect attenuation of cocaine-induced increases in NAc DA while preserving cocaine-induced increases in NAc 5-HT.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 29703999      PMCID: PMC6006258          DOI: 10.1038/s41386-018-0071-3

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  48 in total

Review 1.  Agonist-like, replacement pharmacotherapy for stimulant abuse and dependence.

Authors:  John Grabowski; James Shearer; John Merrill; S Stevens Negus
Journal:  Addict Behav       Date:  2004-09       Impact factor: 3.913

Review 2.  Synthetic cathinones: chemical phylogeny, physiology, and neuropharmacology.

Authors:  Louis J De Felice; Richard A Glennon; Sidney S Negus
Journal:  Life Sci       Date:  2013-11-11       Impact factor: 5.037

3.  The effect of chronic amphetamine treatment on cocaine-induced facilitation of intracranial self-stimulation in rats.

Authors:  Clayton T Bauer; Matthew L Banks; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2014-01-10       Impact factor: 4.530

4.  Use of intracranial self-stimulation to evaluate abuse-related and abuse-limiting effects of monoamine releasers in rats.

Authors:  C T Bauer; M L Banks; B E Blough; S S Negus
Journal:  Br J Pharmacol       Date:  2013-02       Impact factor: 8.739

5.  Pharmacological characterization of designer cathinones in vitro.

Authors:  L D Simmler; T A Buser; M Donzelli; Y Schramm; L-H Dieu; J Huwyler; S Chaboz; M C Hoener; M E Liechti
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

6.  Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusers.

Authors:  Mark K Greenwald; Leslie H Lundahl; Caren L Steinmiller
Journal:  Neuropsychopharmacology       Date:  2010-09-29       Impact factor: 7.853

7.  Potent rewarding and reinforcing effects of the synthetic cathinone 3,4-methylenedioxypyrovalerone (MDPV).

Authors:  Lucas R Watterson; Peter R Kufahl; Natali E Nemirovsky; Kaveish Sewalia; Megan Grabenauer; Brian F Thomas; Julie A Marusich; Scott Wegner; M Foster Olive
Journal:  Addict Biol       Date:  2012-07-11       Impact factor: 4.280

8.  Cocaine self-administration reinforced on a progressive ratio schedule decreases with continuous D-amphetamine treatment in rats.

Authors:  Keri A Chiodo; Christopher M Läck; David C S Roberts
Journal:  Psychopharmacology (Berl)       Date:  2008-07-06       Impact factor: 4.530

9.  Abuse-Related Neurochemical Effects of Para-Substituted Methcathinone Analogs in Rats: Microdialysis Studies of Nucleus Accumbens Dopamine and Serotonin.

Authors:  Julie A Suyama; Farhana Sakloth; Renata Kolanos; Richard A Glennon; Matthew F Lazenka; S Stevens Negus; Matthew L Banks
Journal:  J Pharmacol Exp Ther       Date:  2015-10-15       Impact factor: 4.030

10.  The kappa-opioid agonist U69,593 blocks cocaine-induced enhancement of brain stimulation reward.

Authors:  Hilarie C Tomasiewicz; Mark S Todtenkopf; Elena H Chartoff; Bruce M Cohen; William A Carlezon
Journal:  Biol Psychiatry       Date:  2008-07-17       Impact factor: 13.382

View more
  9 in total

Review 1.  Determinants of opioid abuse potential: Insights using intracranial self-stimulation.

Authors:  S Stevens Negus; Megan J Moerke
Journal:  Peptides       Date:  2018-11-01       Impact factor: 3.750

2.  Role of agonist efficacy in exposure-induced enhancement of mu opioid reward in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Neuropharmacology       Date:  2019-03-14       Impact factor: 5.250

3.  Effects of repeated treatment with methcathinone, mephedrone, and fenfluramine on intracranial self-stimulation in rats.

Authors:  J A Suyama; M L Banks; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2018-09-19       Impact factor: 4.530

4.  Interactions between Cocaine and the Putative Allosteric Dopamine Transporter Ligand SRI-31142.

Authors:  Megan J Moerke; Subramaniam Ananthan; Matthew L Banks; Jose M Eltit; Kelen C Freitas; Amy R Johnson; Surendra K Saini; Tyler W E Steele; S Stevens Negus
Journal:  J Pharmacol Exp Ther       Date:  2018-08-27       Impact factor: 4.030

Review 5.  Interactions between pain states and opioid reward assessed with intracranial self-stimulation in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Neuropharmacology       Date:  2019-07-01       Impact factor: 5.250

6.  Intracranial self-stimulation and concomitant behaviors following systemic methamphetamine administration in Hnrnph1 mutant mice.

Authors:  Kristyn N Borrelli; Carly R Langan; Kyra R Dubinsky; Karen K Szumlinski; William A Carlezon; Elena H Chartoff; Camron D Bryant
Journal:  Psychopharmacology (Berl)       Date:  2021-03-23       Impact factor: 4.530

7.  Temporal parameters of enhanced opioid reward after initial opioid exposure in rats.

Authors:  Megan J Moerke; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2021-01-07       Impact factor: 4.530

8.  Amphetamine maintenance therapy during intermittent cocaine self-administration in rats attenuates psychomotor and dopamine sensitization and reduces addiction-like behavior.

Authors:  Florence Allain; Benoît Delignat-Lavaud; Marie-Pierre Beaudoin; Vincent Jacquemet; Terry E Robinson; Louis-Eric Trudeau; Anne-Noël Samaha
Journal:  Neuropsychopharmacology       Date:  2020-07-18       Impact factor: 7.853

9.  Neuropharmacology of Synthetic Cathinones.

Authors:  Michael H Baumann; Hailey M Walters; Marco Niello; Harald H Sitte
Journal:  Handb Exp Pharmacol       Date:  2018
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.